Johannes Bange

Title: **Johannes Bange: Innovator in Antibody Technology**

Introduction

Johannes Bange is a notable inventor based in Krailling, Germany, recognized for his contributions to the field of biotechnology. With a focus on novel medical applications, his work has significant implications for the treatment of various diseases.

Latest Patents

Bange holds a patent for a human anti-FGFR4 antibody. This invention involves the development of new antibodies targeting the fibroblast growth factor receptor 4 (FGFR4). The patent outlines the medical uses of these antibodies, particularly for the diagnosis, prevention, or treatment of diseases that involve FGFR expression or overactivity. This innovation could potentially lead to groundbreaking therapies in oncology and other related fields.

Career Highlights

Throughout his career, Johannes Bange has been affiliated with prestigious companies including Daiichi Sankyo Europe GmbH and Daiichi Sankyo Company, Limited. His experience at these firms has allowed him to work on advanced medical research, contributing valuable insights and innovations in antibody development.

Collaborations

Bange has collaborated with numerous professionals in his field, including Reimar Abraham and Keisuke Fukuchi. These partnerships have facilitated the exchange of ideas and enhanced the research efforts, leading to significant advancements in their respective projects.

Conclusion

Johannes Bange's work exemplifies the profound impact that inventors can have on medical science. With his patent for the anti-FGFR4 antibody, he is poised to contribute to the evolving field of medical therapeutics, highlighting the importance of innovation in combating complex diseases.